Live News EQUITY M impact May 25, 2026, 07:54 PM UTC

GILD Acquires Tubulis

Gilead Sciences expands oncology portfolio with $3.15B acquisition of Tubulis, bolstering its cancer treatment offerings

SQUAWKNEWS Updated May 27, 2026, 05:32 AM UTC

Gilead Sciences expands oncology portfolio with $3.15B acquisition of Tubulis, bolstering its cancer treatment offerings